Dr. Andrew Aiginin

Andrew Aiginin is Generative Biologics Product Manager at Insilico Medicine, based in Abu Dhabi, UAE. He leads the development and commercialization of generative AI platforms for biologics and drug discovery. Previously trained as a medicinal chemist, he pioneered approaches using protein language models, graph neural networks, and advanced computational methods. He has also co-founded a health-tech startup and led AI-driven drug intelligence initiatives. His work bridges AI model development, experimental validation, and product deployment.